Zobrazeno 1 - 10
of 184
pro vyhledávání: '"D Kirn"'
Autor:
G O, Reynolds, L, Manning, D, Kirn, H, Klein, O, Hampton, O, Burke, R, Buckley, D, Rentz, R, Sperling, G A, Marshall, R E, Amariglio
Publikováno v:
The Journal Of Prevention of Alzheimer's Disease.
With the increasing focus on prevention of Alzheimer's disease, there is need for characterization of preclinical populations. Local participant registries offer an opportunity to facilitate research engagement via remote data collection, inform recr
Autor:
Kotterman M, D Kirn, Holt J, Christopher A. Schmitt, P Szymanski, M Quezada, T Vazin, Roxanne H. Croze, Hassanipour M, G. Beliakoff, K. Barglow, David V. Schaffer, Francis P, Leong M
Targeted AAV vectors are needed for safe and efficient delivery to and transduction of specific tissue target(s) in patients. Effective intravitreal delivery for retina gene therapy is not feasible with wildtype AAV. We employed directed evolution in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16d856b18df0a4914bced918e54fd9d6
https://doi.org/10.1101/2021.06.24.449775
https://doi.org/10.1101/2021.06.24.449775
Autor:
K. Whittlesey, G. Brooks, P. Szymanski, G. Beliakoff, J. Nye, R. Croze, C. Schmitt, J. Bickta, K. Barglow, M. Kotterman, P. Francis, D. Schaffer, D. Kirn
Publikováno v:
TP83. TP083 HEY JUDE - NOVEL FINDINGS FROM OMIC AND BIOINFORMATIC APPROACHES IN PULMONARY HYPERTENSION.
Autor:
Roxanne H. Croze, J. Nye, P Szymanski, Francis P, K. Whittlesey, Hassanipour M, L Johnson, G. Beliakoff, T Vazin, D Schaffer, Kotterman M, Christopher A. Schmitt, G Brooks, M Quezada, D Kirn
Publikováno v:
European Heart Journal. 40
Background Cardiac-targeted gene therapy vectors are needed. Fabry disease is a rare, X-linked disorder caused by mutations in the GLA gene, which encodes α-galactosidase A (GLA). Storage and accumulation of glycolipid substrates of GLA leads to org
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
D, Kirn
Publikováno v:
Ernst Schering Research Foundation workshop. (43)
Autor:
T, Petit, K K, Davidson, C, Cerna, R A, Lawrence, D D, Von Hoff, C, Heise, D, Kirn, E, Izbicka
Publikováno v:
Anti-cancer drugs. 13(1)
The ONYX-015 virus is a mutated adenovirus that in theory selectively replicates and induces cytolysis in tumor cells lacking functional p53. The present study investigated whether ONYX-015 viral infection alone or in combination with conventional ch
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(12)
Replication-selective adenoviruses are being developed as novel anticancer therapeutics. Clinical trials with dl 1520, an E1B-Mr 55,000 gene-deleted adenovirus (ONYX-015), have demonstrated selective viral replication and biological activity in head
Autor:
J, Nemunaitis, I, Ganly, F, Khuri, J, Arseneau, J, Kuhn, T, McCarty, S, Landers, P, Maples, L, Romel, B, Randlev, T, Reid, S, Kaye, D, Kirn
Publikováno v:
Cancer research. 60(22)
ONYX-015 is an E1B-55kDa gene-deleted adenovirus engineered to selectively replicate in and lyse p53-deficient cancer cells. To evaluate the selectivity of ONYX-015 replication and cytopathic effects for the first time in humans, we carried out a Pha
Autor:
I, Ganly, D, Kirn, G, Eckhardt, G I, Rodriguez, D S, Soutar, R, Otto, A G, Robertson, O, Park, M L, Gulley, C, Heise, D D, Von Hoff, S B, Kaye, S G, Eckhardt
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(3)
An E1B 55 kDa gene-deleted adenovirus, Onyx-015, which reportedly selectively replicates in and lyses p53-deficient cells, was administered by a single intratumoral injection to a total of 22 patients with recurrent head and neck cancer. The objectiv